Challenges and recommendations for early identification of metastatic disease in prostate cancer.
Urology
; 83(3): 664-9, 2014 Mar.
Article
in En
| MEDLINE
| ID: mdl-24411213
Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Soft Tissue Neoplasms
/
Bone Neoplasms
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Urology
Year:
2014
Document type:
Article
Country of publication:
United States